Chronic Migraine Epidemiology and Outcomes Study
Completed
- Conditions
- Migraine Disorders
- Registration Number
- NCT01648530
- Lead Sponsor
- Allergan
- Brief Summary
This is a population internet-based study to characterize migraine clinical course and impact on family.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 16789
Inclusion Criteria
- History of migraine
- U.S. Member of Survey Panel
- Household member of study participant
- Ability to complete internet-based questionnaires
Exclusion Criteria
- No access to internet
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Migraine Disability Assessment (MIDAS) 12 Months The Midas score is a patient completed 5-item questionnaire about lost time and productivity (for work, school or family/social activities) in the past 3 months (number of days missed) where: 0-5=Little or No disability, 6-10=Mild disability, 11-20=Moderate disability or 21+ Severe disability. The Midas scores assessed at Months 3, 6, 9 and 12 were averaged.
Percentage of Participants With Episodic Migraine (EM) or Chronic Migraine (CM) Baseline EM is defined as \<15 headache days/month and CM is defined as ≥15 headache days/month.
- Secondary Outcome Measures
Name Time Method